Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06557512 · ClinicalTrials.gov registry record · NA
Adjuvant Hypofractionated Stereotactic Radiosurgery for Intermediate-risk Meningioma
A NA study of Meningioma and Recurrent Meningioma, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- NA
- Development phase
- 23
- Enrollment target
- 1
- Study location
NCT06557512 is a NA study of Meningioma and Recurrent Meningioma that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 23 participants, below the 98-participant average among 21 other Meningioma trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06557512, a NA study of Meningioma and Recurrent Meningioma, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial tests the safety and effectiveness of hypofractionated stereotactic radiosurgery for treating patients who have undergone surgical resection for grade II meningiomas or grade I meningiomas that have come back after a period of improvement (recurrent). Radiation therapy uses high energy x-rays, particles, or radioactive seeds to kill tumor cells and shrink tumors. Stereotactic radiosurgery is a type of external radiation therapy that uses special equipment to position a patient and precisely deliver radiation to tumors in the body. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may kill more tumor cells and have fewer side effects. Hypofractionated stereotactic radiosurgery may be safe, tolerable, and effective in treating patients with grade II or recurrent grade I meningiomas after surgical resection.
Conditions Studied
Interventions
- PROCEDURE Computed Tomography (CT)
- PROCEDURE Magnetic Resonance Imaging (MRI)
- RADIATION Hypofractionated Stereotactic Radiosurgery (SRS)
Study Locations (1)
California
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2024-12-13 |
| Est. Completion | 2029-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06557512
The ClinicalTrials.gov registry entry for NCT06557512 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 98-participant average among 21 other Meningioma trials with a reported enrollment target (77% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Meningioma appearing as the primary indexed condition, and to 3 interventions - of which Computed Tomography (CT) is the first listed.
NCT06557512 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06557512 about?
NCT06557512 is a clinical study titled "Adjuvant Hypofractionated Stereotactic Radiosurgery for Intermediate-risk Meningioma". This clinical trial tests the safety and effectiveness of hypofractionated stereotactic radiosurgery for treating patients who have undergone surgical resection for grade II meningiomas or grade I meningiomas that have come back after a period of improvement (recurrent). Radiation therapy uses high ...
What is the current status of trial NCT06557512?
This trial is currently recruiting. It is a NA study. The enrollment target is 23 participants. The study started on 2024-12-13. Estimated completion is 2029-09-30.
What conditions does trial NCT06557512 study?
This clinical trial studies the following conditions: Meningioma, Recurrent Meningioma, Meningioma, Malignant.
What interventions are being tested in trial NCT06557512?
The interventions under investigation include: Computed Tomography (CT) (PROCEDURE), Magnetic Resonance Imaging (MRI) (PROCEDURE), Hypofractionated Stereotactic Radiosurgery (SRS) (RADIATION).
Who is sponsoring clinical trial NCT06557512?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06557512 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Meningioma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of the CONVIVO System
RECRUITING · NA
-
HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)
RECRUITING · NA
-
A Trial of Increased Dose Intensity Modulated Proton Therapy (IMPT) for High-Grade Meningiomas
ACTIVE NOT RECRUITING · NA
-
Information Presentation Formats
COMPLETED · NA
-
Stereotactic Body Radiotherapy for Spine Tumors
COMPLETED · NA
-
Abemaciclib in Newly Diagnosed Meningioma Patients
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.